A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer.
about
A metastasis biomarker (MetaSite Breast™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A metastasis biomarker (MetaSi ...... ive early-stage breast cancer.
@en
A metastasis biomarker (MetaSi ...... ive early-stage breast cancer.
@nl
type
label
A metastasis biomarker (MetaSi ...... ive early-stage breast cancer.
@en
A metastasis biomarker (MetaSi ...... ive early-stage breast cancer.
@nl
prefLabel
A metastasis biomarker (MetaSi ...... ive early-stage breast cancer.
@en
A metastasis biomarker (MetaSi ...... ive early-stage breast cancer.
@nl
P2093
P2860
P1433
P1476
A metastasis biomarker (MetaSi ...... ive early-stage breast cancer.
@en
P2093
Anthony Shuber
David Entenberg
Douglas A Hamilton
Frank Gertler
Joan Jones
John Condeelis
Joseph A Sparano
Lori J Goldstein
Maja H Oktay
Michael Donovan
P2860
P2888
P356
10.1038/S41523-017-0043-5
P577
2017-11-08T00:00:00Z